Inventor · disambiguated record
E. Lerner
Also filed as: LERNER E I · LERNER E ITZHAK
16 granted patents·29 pending applications·1,458 citations·filing 1996–2015
95Inventor score
Top patents by PatentIndex Score
45 records- 0197US6531152B1Immediate release gastrointestinal drug delivery systemDEXCEL PHARMA TECHNOLOGIES LTD·Filed 2000·Granted Mar 11, 2003·240 cites·44 claims
- 0297US6197331B1Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavityPERIO PROD LTD·Filed 1997·Granted Mar 6, 2001·317 cites·19 claims
- 0396US7195778B2Drug delivery system for zero order, zero order-biphasic, ascending or descending drug deliveryTEVA PHARMA·Filed 2002·Granted Mar 27, 2007·177 cites·44 claims
- 0496US5840332AGastrointestinal drug delivery systemPERIO PROD LTD·Filed 1996·Granted Nov 24, 1998·302 cites·21 claims
- 0594US8663703B2Drug microparticles, processes of preparing them and a drug delivery vehicle comprising themLERNER E ITZHAK·Filed 2009·Granted Mar 4, 2014·62 cites·8 claims
- 0694US6881420B2Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferationTEVA PHARMA·Filed 2001·Granted Apr 19, 2005·58 cites·25 claims
- 0792US6231888B1Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polypsPERIO PROD LTD·Filed 1998·Granted May 15, 2001·122 cites·61 claims
- 0891US6632451B2Delayed total release two pulse gastrointestinal drug delivery systemDEXCEL PHARMA TECHNOLOGIES LTD·Filed 1999·Granted Oct 14, 2003·131 cites·36 claims
- 0988US8188067B2Formulations of 6-mercaptopurineLERNER E ITZHAK·Filed 2005·Granted May 29, 2012·9 cites·21 claims
- 1087US9375403B2Formulations of 6-mercaptopurineTEVA PHARMA·Filed 2015·Granted Jun 28, 2016·3 cites·15 claims
- 1186US8653060B2Formulations of 6-mercaptopurineLERNER E ITZHAK·Filed 2012·Granted Feb 18, 2014·5 cites·20 claims
- 1285US9180097B2Formulations of 6-mercaptopurineTEVA PHARMA·Filed 2014·Granted Nov 10, 2015·3 cites·12 claims
- 1385US7611722B2Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing itTEVA PHARMA·Filed 2003·Granted Nov 3, 2009·18 cites·32 claims
- 1479US9107832B2Risperidone microparticles formed by sublimationTEVA PHARMA·Filed 2014·Granted Aug 18, 2015·1 cites·8 claims
- 1577US7674480B2Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the compositionTEVA PHARMA·Filed 2001·Granted Mar 9, 2010·10 cites·24 claims
- 1663US2006141051A1Drug microparticlesLERNER E I·Filed 2006·Application pending·0 cites
- 1763US2006141052A1Drug microparticlesLERNER E I·Filed 2006·Application pending·0 cites
- 1862US2006233879A1Controlled released dosage formsTEVA PHARMA·Filed 2006·Application pending·0 cites
- 1962US2006233880A1Controlled release dosage formsTEVA PHARMA·Filed 2006·Application pending·0 cites
- 2061US2005048086A1Compositions and dosage forms for gasteric delivery of antineoplastic agents and methods of treatment that use them to inhibit cancer cell proliferationFiled 2004·Application pending·0 cites
- 2161US2010278912A1Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the compositionTEVA PHARMACEUTICALS USA INC F·Filed 2007·Application pending·0 cites
- 2258US2003224059A1Drug microparticlesFiled 2003·Application pending·0 cites
- 2357US2005112202A1Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing itFiled 2004·Application pending·0 cites
- 2455US2007178149A1Levodopa compositionsFLASHNER-BARAK MOSHE·Filed 2006·Application pending·0 cites
- 2553US2004122065A1Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or buccallyFiled 2003·Application pending·0 cites
- 2653US2005026871A1Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivativeFiled 2003·Application pending·0 cites
- 2752US2009042914A1Delayed release formulations of 6-mercaptopurineTEVA PHARMA·Filed 2008·Application pending·0 cites
- 2852US2006222706A1Formulations of FenofibrateFLASHNER-BARAK MOSHE·Filed 2005·Application pending·0 cites
- 2951US7579333B2Therapy using a combination of raloxifene and alendronateTEVA PHARMA·Filed 2005·Granted Aug 25, 2009·0 cites·21 claims
- 3051US2004092577A1Microparticle pharmaceutical compositions for intratumoral deliveryFiled 2003·Application pending·0 cites
- 3151US2004198646A1Menthol solutions of drugsFiled 2004·Application pending·0 cites
- 3251US2001024657A1Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavityFiled 2001·Application pending·0 cites
- 3349US2006141028A1Cyclosporin formulationsFLASHNER-BARAK MOSHE·Filed 2005·Application pending·0 cites
- 3449US2007148233A1Pharmaceutical formulations of fenofibrate having improved bioavailabilityLERNER E I·Filed 2005·Application pending·0 cites
- 3549US2006222707A1Formulations of fenofibrateLERNER E I·Filed 2006·Application pending·0 cites
- 3649US2007015834A1Formulations of fenofibrate containing PEG/PoloxamerFLASHNER-BARAK MOSHE·Filed 2005·Application pending·0 cites
- 3749US2007015833A1Formulations of fenofibrate containing mentholFLASHNER-BARAK MOSHE·Filed 2005·Application pending·0 cites
- 3847US2005170004A1Nanoparticles for drug deliveryFiled 2004·Application pending·0 cites
- 3947US2006153918A1Dosage forms with an enterically coated core tabletLERNER E I·Filed 2005·Application pending·0 cites
- 4047US2005113452A1Composition and dosage form for sustained effect of levodopaFiled 2004·Application pending·0 cites
- 4145US2005192340A1Simvastatin formulations and methods of making sameFiled 2004·Application pending·0 cites
- 4245US2006008520A1Delayed release formulations of 6-mercaptopurineLERNER E I·Filed 2005·Application pending·0 cites
- 4340US2004052843A1Controlled release dosage formsFiled 2003·Application pending·0 cites
- 4439US2008057129A1Drug microparticlesLERNER E I·Filed 2007·Application pending·0 cites
- 4538US2006018957A1Pharmaceutical dosage forms including rasagilineLERNER E I·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when E. Lerner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →